PET/CT imaging of atherosclerotic blood vessel alterations;Bildgebung atherosklerotischer Gefäwandveränderungen mit der PET/CT

Radiologe

Volumn 50, Issue 4, 2010, Pages 355-365

  Rominger, A ^a   Rist, C ^a   Nikolaou, K ^a   Reiser, M F ^a   Bartenstein, P ^a   Hacker, M ^a   Saam, T ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Inflammation; Molecular imaging; PET CT; Vulnerable plaque

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AGED; ARTICLE; ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE SUBTRACTION; MALE; METABOLISM; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77952669106     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-009-1969-x     Document Type: Article

References (30)

1. Ben-Haim S, Kupzov E, Tamir A et al (2004) Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med 45:1816-1821
2. Blockmans D, Bley T, Schmidt W (2009) Imaging for large-vessel vasculitis. Curr Opin Rheumatol 21:19-28
3. Bural GG, Torigian DA, Chamroonrat W et al (2008) FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging 35:562-569
4. Cyran C, Saam T, Sourbron S et al (2009) Quantification of arterial wall inflammation in patients with arteriitis using high-resolution DCE-MRI: correlation with 18F-FDG PET/CT. European congress of radiology 2009, March 6th-10th, Vienna, Austria. ECR 19, S1:B-070
5. Fuster V, Badimon L, Badimon JJ et al (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326:310-318
6. Fuster V, Stein B, Ambrose JA et al (1990) Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 82:II47-II59
7. Hansson GK (2005) Inflammation, atherosclerosis and coronary artery disease. N Engl J Med 352:1685-1695
8. Kato K, Schober O, Ikeda M et al (2009) Evaluation and comparison of (11)C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging 36:1622-1628
9. Kietselaer BL, Reutelingsperger CP, Heidendal GA et al (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350:1472-1473
10. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
11. Little WC, Constantinescu M, Applegate RJ et al (1988) Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78:1157-1166
12. Lloyd-Jones D, Adams R, Carnethon M et al (2009) Heart disease and stroke statistics - 2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 119:e21-e181
13. Menezes LJ, Kotze CW, Hutton BF et al (2009) Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med 50:854-857
14. Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108:1664-1672 (Pubitemid 37243650)
15. Nikolaou K, Knez A, Rist C et al (2006) Accuracy of 64-MDCT in the diagnosis of ischemic heart disease. AJR Am J Roentgenol 187:111-117
16. Paulmier B, Duet M, Khayat R et al (2008) Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol 15:209-217
17. Rominger A, Saam T, Vogl E et al (2010) In vivo imaging of macrophage activity in the coronary arteries using 68-Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. J Nucl Med, in press
18. Rominger A, Saam T, Wolpers S et al (2009) 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med 50:1611-1620
19. Rudd JH, Myers KS, Bansilal S et al (2008) Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods and recommendations. J Nucl Med 49:871-878
20. Rudd JH, Myers KS, Bansilal S et al (2007) (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 50:892-896
21. Rudd JH, Warburton EA, Fryer TD et al (2002) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105:2708-2711
22. Saam T, Ferguson MS, Yarnykh VL et al (2005) Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 25:234-239
23. Saam T, Hatsukami TS, Takaya N et al (2007) The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 244:64-77 (Pubitemid 46981959)
24. Saam T, Rominger A, Wolpers S et al (n d) Association of inflammation of the left coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. EJNMMI (under review)
25. Tahara N, Kai H, Ishibashi M et al (2006) Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48:1825-1831
26. Tahara N, Kai H, Yamagishi S et al (2007) Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol 49:1533-1539
27. Tatsumi M, Cohade C, Nakamoto Y et al (2003) Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 229:831-837
28. Tawakol A, Migrino RQ, Hoffmann U et al (2005) Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 12:294-301
29. Virmani R, Burke AP, Farb A et al (2002) Pathology of the unstable plaque. Prog Cardiovasc Dis 44:349-356
30. Wykrzykowska J, Lehman S, Williams G et al (2009) Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med 50:563-568